Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,698.79
(
-0.26%
)
US TECH 100
24,048.00
(
-0.35%
)
Dow Jones
46,814.19
(
-0.38%
)
Brent Oil
105.38
(
4.69%
)
Bitcoin
72,498.44
(
-1.95%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 133752

Friday, 12/23/2011 6:16:27 PM

Friday, December 23, 2011 6:16:27 PM

Post# of 257253
Four bullish things for MNTA that could happen at any time
(options players beware):

• FDA approval of generic Copaxone.

• A partnership deal for M402.

• Monetization of MNTA’s Lovenox income stream.

• A buyout offer.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up